Mounjaro (Tirzepatide) 12.5 mg KwikPen

Mounjaro (Tirzepatide) 12.5 mg KwikPen

Mounjaro is now available in Bali via BaliPharma after consultation. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes and, alongside diet and exercise, to support weight management.

Composition: Tirzepatide 12.5 mg per pre-filled pen.

Packaging: One pre-filled KwikPen delivering the 12.5 mg dose.

How to use: Administer by subcutaneous injection once weekly, exactly as directed by your prescribing clinician. Rotate injection sites (abdomen, thigh, or upper arm).

Side effects: The most common side effects include nausea, diarrhoea, decreased appetite, vomiting, constipation, and injection-site reactions. Contact your clinician if effects persist or worsen.

Warnings & storage: Not for use in type 1 diabetes. Store refrigerated at 2°C–8°C; do not freeze. Keep out of reach of children.

Prescription information: Mounjaro is a prescription-only medicine. Mounjaro is now available in Bali via BaliPharma after consultation. Book your consultation at BaliDoc.com to determine whether this treatment is suitable for you.